CITTERIO STEFANIA
- U03, Piano: 2, Stanza: 2027B
Pubblicazioni
Fontana, D., Mauri, M., Renso, R., Docci, M., Crespiatico, I., Rost, L., et al. (2020). ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine. BLOOD, 136(Supplement_2), LBA-5-LBA-5 [10.1182/BLOOD-2020-143852]. Dettaglio
Fontana, D., Mauri, M., Niro, A., Massimino, L., Bertagna, M., Zambrotta, G., et al. (2018). ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION. Intervento presentato a: XV Congress of the Italian Society of Experimental Hematology, Rimini, Italy. Dettaglio
Mologni, L., Costanza, M., Sharma, G., Viltadi, M., Massimino, L., Citterio, S., et al. (2018). Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells. NEOPLASIA, 20(5), 467-477 [10.1016/j.neo.2018.02.009]. Dettaglio
Fumagalli, S., Torri, A., Papagna, A., Citterio, S., Mainoldi, F., Foti, M. (2016). IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. SCIENTIFIC REPORTS, 6 [10.1038/srep33900]. Dettaglio
Sharma, N., Magistroni, V., Piazza, R., Citterio, S., Mezzatesta, C., Khandelwal, P., et al. (2015). BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene. MOLECULAR CANCER, 14(1) [10.1186/s12943-015-0407-0]. Dettaglio